THE IMPACT OF COVID-19 ON RESPIRATORY TRACT MICROBIOTA PATTERN IN PATIENTS WITH SEVERE PNEUMONIA
- Authors: Zolotov M.O.1, Kozlov A.V.1, Shafigullina L.R.1, Lyamin A.V.1
-
Affiliations:
- Research and Educational Professional Center for Genetic and Laboratory Technologies, Samara State Medical University, Russian Federation
- Section: SHORT COMMUNICATIONS
- Submitted: 28.03.2025
- Accepted: 01.08.2025
- URL: https://iimmun.ru/iimm/article/view/17903
- DOI: https://doi.org/10.15789/2220-7619-TIO-17903
- ID: 17903
Cite item
Full Text
Abstract
Abstract
COVID-19 weakens the body's immune system and predisposes to bacterial co-infections. It has been increasingly evident about changes in the etiological pattern of pneumonia pathogens due to altered lung microbiota after viral pneumonia, the effect of SARS-CoV-2 on the immune system, and antibiotics taking as part of preventing secondary bacterial coinfection. Our study was aimed to analyze the dynamic change in the pattern of the respiratory tract microbiota in patients with severe pneumonia in the years from 2019 to 2023. There were enrolled 304 patients with pneumonia diagnosed after X-ray examination assessed from January 2019 to December 2023 inclusive. During the pandemic, all the investigated patients had a positive SARS-CoV-2 PCR result, and in the period after the pandemic all the examined patients were negative. Sputum samples delivered to the laboratory, where we performed microbiological culture with identification by MALDI-TOF mass spectrometry. In the pre-COVID-19 pandemic, 62 sputum samples were analyzed, among which Klebsiella pneumoniae and Stenotrophomonas maltophilia were the most common found in 21% and 17,7%, respectively. Both Acinetobacter baumanii and Staphylococcus aureus were isolated in 14,5% cases. Streptococcus pneumoniae was found in 8.1%cases. During the COVID-19 pandemic, 122 samples were evaluated allowing to observe that K. pneumoniae accounted for half of all isolated microorganisms. The second most common was A. baumannii (23,8%). In the post-pandemic period, 120 samples were analyzed, from which K. pneumoniae was mainly identified (31,7%). The next most frequent among pathogens were S. aureus and A. baumannii – 23,3% and 18,3%, respectively. In this way, there was a statistically significant change in the frequency of detection of Gram-positive and Gram-negative microorganisms in ICU patients during the study periods. Before the COVID-19 pandemic, the proportion of Gram-negative microorganisms in the pattern of pathogens was 67,7%, during the pandemic – 91,0%, in the post-pandemic period – approached the values of 2019-2020 and amounted to 70,0% (p<0.001). K. pneumoniae and A. baumannii were the most frequently found, however, the statistical significance of the changes was observed only for K. pneumoniae (p<0.005). An insignificant decline in the detection rate of pneumococcus was established as well. The frequency of staphylococcal discharge after coronavirus infection exceeded the pre-pandemic magnitude (p<0.001).
About the authors
Maksim O. Zolotov
Research and Educational Professional Center for Genetic and Laboratory Technologies, Samara State Medical University, Russian Federation
Email: m.o.zolotov@samsmu.ru
SPIN-code: 8327-4019
PhD, Head of the Laboratory of Interdisciplinary Relations of Research and Educational Professional Center for Genetic and Laboratory Technologies.
Россия, 443079, Russian Federation, Samara,Gagarina st. 20.Andrei V. Kozlov
Research and Educational Professional Center for Genetic and Laboratory Technologies, Samara State Medical University, Russian Federation
Email: a.v.kozlov@samsmu.ru
ORCID iD: 0000-0001-9384-6854
SPIN-code: 6871-1845
PhD, Head of Laboratory of molecular pathology of Research and Educational Professional Center for Genetic and Laboratory Technologies.
Россия, 443079, Russian Federation, Samara,Gagarina st. 20.Liliya R. Shafigullina
Research and Educational Professional Center for Genetic and Laboratory Technologies, Samara State Medical University, Russian Federation
Author for correspondence.
Email: l.r.shafigullina@samsmu.ru
ORCID iD: 0009-0009-2363-3701
SPIN-code: 3191-3673
Specialist of Laboratory of molecular pathology of Research and Educational Professional Center for Genetic and Laboratory Technologies.
Россия, 443079, Russian Federation, Samara,Gagarina st. 20.Artem V. Lyamin
Research and Educational Professional Center for Genetic and Laboratory Technologies, Samara State Medical University, Russian Federation
Email: avlyamin@rambler.ru
ORCID iD: 0000-0002-5905-1895
MD, Head of Research and Educational Professional Center for Genetic and Laboratory Technologies.
Россия, 443079, Russian Federation, Samara,Gagarina st. 20.References
- Авдеева М.Г., Кулбужева М.И., Зотов С.В., Журавлева Е.В., Яцукова А.В. Микробный пейзаж у госпитальных больных с новой коронавирусной инфекцией COVID-19, сравнительная антибиотикорезистентность с «доковидным» периодом: проспективное исследование // Кубанский научный медицинский вестник. 2021. Т. 28, № 5, С 14-28.
- Временные методические рекомендации «Профилактика, диагностика, и лечение новой коронавирусной инфекции (COVID-19)». Версия 18. От 26.10.2023 г.
- Иванова И.А., Омельченко Н.Д., Филиппенко А.В., Труфанова А.А., Носков А.К. Роль клеточного звена иммунитета в формировании иммунного ответа при коронавирусных инфекциях // Медицинская иммунология. 2021. Т.23, №6. С.1229-1238.
- Теплова Н.В., Ромашов О.М., Амелина Я.Г. Коронавирусная инфекция и бактериальная пневмония: актуальные акценты и курс на рациональную антибиотикотерапию // Лечебное дело. 2024. №1. С.8-14.
- Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., Xia J., Yu T., Zhang X., Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet., 2020, vol. 395, no. 10223, pp. 507-513.
- Chung Y.S., Lam C.Y., Tan P.H., Tsang H.F., Wong S.C. Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies. Int. J. Mol. Sci., 2024, vol. 25, no 15, pp. 8155.
- Fazel P., Sedighian H., Behzadi E., Kachuei R., Imani Fooladi A. A. Interaction Between SARS-CoV-2 and Pathogenic Bacteria. Curr Microbiol, 2023, vol. 80, no. 7, pp. 223.
- Hespanhol V., Bárbara C. Pneumonia mortality, comorbidities matter?. Pulmonology, 2020, vol. 26, no. 3, pp. 123-129.
- Juan C.H., Fang S.Y., Chou C.H., Tsai T.Y., Lin Y.T. Clinical characteristics of patients with pneumonia caused by Klebsiella pneumoniae in Taiwan and prevalence of antimicrobial-resistant and hypervirulent strains: a retrospective study. Antimicrob Resist Infect Control., 2020, vol. 9, no. 1, pp. 4.
- Lansbury L., Lim B., Baskaran V., Lim W.S. Co-infections in people with COVID-19: a systematic review and meta-analysis. J. Infect., 2020, vol. 81, no. 2, pp. 266–275.
- Mirzaei R., Goodarzi P., Asadi M., Soltani A., Aljanabi H. A. A., Jeda A. S., Dashtbin S., Jalalifar S., Mohammadzadeh R., Teimoori A., Tari K., Salari M., Ghiasvand S., Kazemi S., Yousefimashouf R., Keyvani H., Karampoor S. Bacterial co-infections with SARS-CoV-2. IUBMB Life, 2020, vol. 72, no. 10, pp. 2097-2111.
- Principi N., Autore G., Ramundo G., Esposito S. Epidemiology of Respiratory Infections during the COVID-19 Pandemic. Viruses, 2023, vol. 15, no. 5, pp. 1160.
- Sulayyim H.J.A., Ismail R., Hamid A.A., Ghafar N.A. Antibiotic Resistance during COVID-19: A Systematic Review. Int J Environ Res, 2022, vol. 19, no. 19, pp. 11931.
- Westblade L.F., Simon M.S., Satlin M.J. Bacterial Coinfections in Coronavirus Disease 2019. Trends Microbiol, 2021, vol. 29, no. 10, pp. 930-941.
Supplementary files
